Cargando…

Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems

OBJECTIVE: Glucose-dependent insulinotropic polypeptide (GIP) is one of the two major incretin factors that regulate metabolic homeostasis. Genetic ablation of its receptor (GIPR) in mice confers protection against diet-induced obesity (DIO), while GIPR neutralizing antibodies produce additive weigh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Bin, Gelfanov, Vasily M., El, Kimberley, Chen, Alex, Rohlfs, Rebecca, DuBois, Barent, Kruse Hansen, Ann Maria, Perez-Tilve, Diego, Knerr, Patrick J., D'Alessio, David, Campbell, Jonathan E., Douros, Jonathan D., Finan, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719863/ https://www.ncbi.nlm.nih.gov/pubmed/36400403 http://dx.doi.org/10.1016/j.molmet.2022.101638

Ejemplares similares

Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
por: Mroz, Piotr A., et al.
Publicado: (2018)

The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets
por: El, Kimberley, et al.
Publicado: (2023)

Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism
por: Killion, Elizabeth A., et al.
Publicado: (2020)

Gipr Is Essential for Adrenocortical Steroidogenesis; However, Corticosterone Deficiency Does Not Mediate the Favorable Metabolic Phenotype of Gipr(−/−) Mice
por: Bates, Holly E., et al.
Publicado: (2012)

Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
por: Campbell, Jonathan E.
Publicado: (2020)

Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
por: Knerr, Patrick J., et al.
Publicado: (2022)

The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling
por: Zhang, Qian, et al.
Publicado: (2021)

Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant
por: Yammine, Lucie, et al.
Publicado: (2023)

GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys
por: Lu, Shu-Chen, et al.
Publicado: (2021)

A viral insulin-like peptide is a natural competitive antagonist of the human IGF-1 receptor
por: Zhang, Fa, et al.
Publicado: (2021)

Genetic disruption of the Gipr in Apoe(−/−) mice promotes atherosclerosis
por: Pujadas, Gemma, et al.
Publicado: (2022)

Effects of chronic cirrhosis induced by intraperitoneal thioacetamide injection on the protein content and Michaelis–Menten kinetics of cytochrome P450 enzymes in the rat liver microsomes
por: Chandrashekar, Devaraj Venkatapura, et al.
Publicado: (2022)

Reagents and models for detecting endogenous GLP1R and GIPR
por: Ast, Julia, et al.
Publicado: (2021)

GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior
por: Samms, Ricardo J., et al.
Publicado: (2022)

Genetically proxied impaired GIPR signaling and risk of 6 cancers
por: Rogers, Miranda, et al.
Publicado: (2023)

The gut hormone receptor GIPR links energy availability to the control of hematopoiesis
por: Pujadas, Gemma, et al.
Publicado: (2020)

GIPR rs10423928 and bone mineral density in postmenopausal women in Shanghai
por: Zhang, Lizhi, et al.
Publicado: (2022)

Molecular basis of signal transduction mediated by the human GIPR splice variants
por: Zhao, Fenghui, et al.
Publicado: (2023)

The Link between Three Single Nucleotide Variants of the GIPR Gene and Metabolic Health
por: Michałowska, Joanna, et al.
Publicado: (2022)

Temporal plasticity of insulin and incretin secretion and insulin sensitivity following sleeve gastrectomy contribute to sustained improvements in glucose control
por: Douros, Jonathan D., et al.
Publicado: (2019)

GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice
por: Quarta, Carmelo, et al.
Publicado: (2022)

Activation of GIPR Exerts Analgesic and Anxiolytic-Like Effects in the Anterior Cingulate Cortex of Mice
por: Wang, Xin-shang, et al.
Publicado: (2022)

Evaluation of AMG 076, a potent and selective MCHR1 antagonist, in rodent and primate obesity models
por: Motani, Alykhan S, et al.
Publicado: (2013)

The Methylation Analysis of the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Locus in GH-Secreting Pituitary Adenomas
por: Dalle Nogare, Mattia, et al.
Publicado: (2023)

Molecular Characterization of Grass Carp GIPR and Effect of Nutrition States, Insulin, and Glucagon on Its Expression
por: Yang, Guokun, et al.
Publicado: (2022)

Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells
por: Manchanda, Yusman, et al.
Publicado: (2023)

Resistin Knockout Mice Exhibit Impaired Adipocyte Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Expression
por: Kim, Su-Jin, et al.
Publicado: (2013)

Discovery and Identification of Pyrazolopyramidine Analogs as Novel Potent Androgen Receptor Antagonists
por: Wang, Lingyan, et al.
Publicado: (2018)

Discovery of Natural Products as Novel and Potent FXR Antagonists by Virtual Screening
por: Diao, Yanyan, et al.
Publicado: (2018)

Discovery of Potent Peptidomimetic Antagonists for Heterochromatin Protein 1 Family Proteins
por: Lamb, Kelsey N., et al.
Publicado: (2021)

Discovery of Potent Tetrazole Free Fatty Acid Receptor 2 Antagonists
por: Valentini, Alice, et al.
Publicado: (2023)

Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist
por: Chan, John D., et al.
Publicado: (2016)

GIPR Function in the Central Nervous System: Implications and Novel Perspectives for GIP-Basedz Therapies in Treating Metabolic Disorders
por: Samms, Ricardo J., et al.
Publicado: (2021)

Association of gastric inhibitory polypeptide receptor (GIPR) gene polymorphism with type 2 diabetes mellitus in iranian patients
por: Erfanian, Saiedeh, et al.
Publicado: (2023)

SAT062 Inhibition Of GIPR Expression Enhances Sulfonylurea-induced Insulin Secretion, And It Was Associated With Changes In ATP Contents
por: Ah Kim, Hyun, et al.
Publicado: (2023)

Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: The Ultimate Antagonist (I)
por: Vojdani, Aristo, et al.
Publicado: (2006)

Interaction of a viral insulin-like peptide with the IGF-1 receptor produces a natural antagonist
por: Moreau, Francois, et al.
Publicado: (2022)

Dual GIPR and GLP-1R agonist tirzepatide inhibits aeroallergen-induced allergic airway inflammation in mouse model of obese asthma
por: Toki, Shinji, et al.
Publicado: (2023)

GIPR rs1800437 polymorphism: prevalence and possible associations with metabolic syndrome-related diseases in a Brazilian urban population
por: da Silva Mattos, Alexandro Marcio, et al.
Publicado: (2015)

Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the GIPR Region
por: Bowker, Nicholas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m3lsgju85k1j471ov5sf1n1ql0